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ABSTRACT 
Phenolic bioactives from plant-based 
foods have significant antioxidative and 
associated medicinal and therapeutic 
properties and can be targeted against 
oxidative stress-linked chronic diseases such 
as type 2 diabetes (T2D). Legumes with 
phenolic antioxidant-linked human health 
function has both agro-ecological and public 
health benefits. Since phenolic bioactives vary 
among diverse genotypes, the major aim of 
this study was to screen and investigate the 
phenolic antioxidant-linked anti-
hyperglycemic functionality of snap bean 
(Phaseolus vulgaris) genotypes as dietary and 
potential therapeutic target against early 
stages of T2D. The aqueous extracts of 5 
genotypes of commonly consumed green snap 
bean pods grown separately under field and 
greenhouse conditions were investigated for 
total soluble phenolic content (TSP), phenolic 
acid profile, total antioxidant (TA) activity, α-
amylase, and α-glucosidase enzyme inhibitory 
activities using in vitro assay models. Among 
genotypes, OR 5630 had moderate TSP 
content, moderate to high TA activity, and 
high α-amylase enzyme inhibitory activity, 
while moderate α-glucosidase enzyme 
inhibitory activity was observed in Ebro and 
Eagle genotypes both in the field and 
greenhouse grown pods. Therefore, the 
genotypes with moderate phenolic 
antioxidant-linked anti- hyperglycemic 
properties can be further investigated in vivo 
studies with animal models to integrate with 
healthy dietary intervention strategies or for 
potential therapeutic and medicinal 
applications against early stages of T2D and 
its associated complications. 
INTRODUCTION 
Diverse biological functions of secondary 
metabolites, such as phenolic bioactives in food 
crops provide multiple opportunities to utilize 
them for medicinally relevant human health 
applications including in dietary and potential 
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therapeutic strategies against non-communicable 
chronic diseases (NCDs). Although human cells 
cannot produce phenolic antioxidants 
themselves, dietary consumption of these 
phenolic bioactives or targeting them for 
therapeutic strategies from plant-based sources 
has diverse health benefits, especially against 
chronic oxidative stress-linked NCDs, such as 
T2D (Kahn et al., 2014; Pandey and Rizvi, 2009). 
Phenolic antioxidants of plant-based foods can 
either directly offset cellular damages caused by 
reactive oxygen species (ROS) (Rice-Evans et 
al., 1997) or can induce endogenous antioxidant 
enzyme responses when consumed as a part of 
the diet or targeted in therapeutic and medicinal 
applications (Shetty and Wahlqvist, 2004). 
Animal cells including human cells typically 
respond to these phenolic bioactives mainly 
through direct interactions with receptors or 
enzymes involved in metabolic processes of 
digestion, signal transduction, or through 
modifying gene expressions which may result 
from modification of the redox status of the cell 
induced from a series of redox- dependent 
reactions (Shalaby and Horwitz, 2015; Tsao and 
Rong, 2010). Therefore, when consumed or 
targeted in therapeutic and medicinally relevant 
strategies, phenolic bioactives can help in 
maintaining redox homeostasis by countering 
ROS-induced chronic oxidative stresses, which 
are commonly associated with hyperglycemia 
linked to T2D (Rochette et al., 2014). Beyond 
such specific bioactive role as a redox regulator, 
there are strong evidences of other important 
protective health relevant benefits of phenolic 
antioxidants of food crops modulating and 
inhibiting key disease pathways (Sarkar and 
Shetty, 2014; Shetty and Wahlqvist, 2004). 
Numerous such protective functions of 
phenolic bioactives are associated with cardio-
protection, anti-cancer, anti-aging, neuro-
protection, and anti-diabetes benefits 
(Fernandez-Panchon et al., 2008; Pandey and 
Rizvi, 2009; Shahidi and Ambigaipalan, 2015). 
Phenolic bioactives and their metabolites also 
influence digestion, absorption, and metabolism 
of dietary carbohydrates (such as starch and 
sucrose), which has direct implications for T2D 
management (Hanhineva et al., 2010; McCue 
and Shetty, 2004). Specifically, phenolic 
bioactives from cereal grains, legumes, 
vegetables, and fruits potentially influence 
glucose metabolism in part by inhibiting α-
amylase, and α-glucosidase enzyme activities, 
which are key digestive enzymes responsible for 
carbohydrate digestion and glucose absorption 
in the small intestine (Hanhineva et al., 2010; 
McCue and Shetty, 2004). Inhibition of these 
digestive enzymes could reduce the rate of 
glucose release and absorption in the small 
intestine and subsequently suppress 
postprandial hyperglycemia and therefore, 
dietary phenolics are excellent diet-based 
therapeutic targets to manage early stages of 
T2D (Hanhineva et al., 2010; Sarkar and Shetty, 
2014). Previous in vitro studies have reported 
that phenolic bioactives of food crops, including 
legumes posses significant α-amylase and α-
glucosidase enzyme inhibitory activities and can 
be targeted in dietary and therapeutic strategies 
to manage early stages of T2D (Hanhineva et al., 
2010, Kwon et al., 2007; Ranilla et al., 2009; 
Singhal et al., 2014). Apart from this specific 
digestive role in improving glucose metabolism, 
legumes are also considered as an important 
antidote for preventing and managing T2D-
linked cardiovascular diseases (Jukanti et al., 
2017). 
Most edible legumes also have a higher 
amount of resistant starch and amylose in the 
seeds which are resistant to rapid digestion in 
the small intestine and ultimately resulting in 
lower availability of glucose (Jukanti et al., 
2017). The lower bioavailability coupled with 
slower entry of glucose in the bloodstream 
reduce the demand for insulin and thus lower the 
glycemic index and insulinemic postprandial 
response (Jukanti et al., 2017). In addition, 
legumes including common green beans and 
peas are also high in soluble and insoluble fiber, 
low in sodium and fat, and are an excellent 
source of complex carbohydrates, B vitamins, 
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folate, and minerals such as calcium, iron, 
magnesium and potassium (Roy et al., 2010). 
Fresh green beans including snap beans contain 
quercetin and kaempferol classes of phenolics 
and fresh pods have more complex phenolic 
profile compared to seeds (Escarpa and 
González, 2000). Higher anti- hyperglycemic 
properties and improvement in collagen 
accumulation was observed in in vivo animal 
model studies with green bean pod extracts (Pari 
and Venkateswaran, 2003; Roman-Ramos et al., 
1995). Howvever, such human health relevant 
phenolic bioactive profiles of common snap 
beans vary significantly with cultivation and 
growing conditions, genotypes, and with other 
phenotypic traits (Kleintop et al., 2016). 
Although higher consumption of easy to use 
fresh snap bean has been encouraged due to 
diverse potential human health benefits, 
however a gap exists in biochemical rationale-
based evidences for phenolic antioxidant-linked 
anti-hyperglycemic properties of specific snap 
bean genotypes and based on their different 
growing conditions that can be targeted for 
medicinally relevant health benefits. Therefore, 
the major aim of this study was to develop a 
strategy to screen different snap bean genotypes 
for their phenolic antioxidant-linked 
antihyperglycemic properties using rapid in 
vitro assay models and comparing between field 
and greenhouse grown snap bean pods as a 
biochemical rationale-based foundation for 
further long-term dietary and therapeutic 
applications as well as basis for further crop 
breeding strategies. 
MATERIALS AND METHODS 
Materials. In this study, green pods of 5 
different genotypes of snap beans (Phaseolus 
vulgaris L.) (Bogota, Eagle, Ebro, Oregon 5630, 
and Tendergreen) were evaluated. Selection of 
these snap bean genotypes was based on their  
genetic diversity and common use of these 
genotypes in the market. Green pods of these 
snap bean genotypes were obtained from the 
Oregon State University, Corvallis, USA, in 
2014 (from Bean CAP Snap Bean Diversity 
Panel) and frozen snap bean samples were 
analyzed at North Dakota State University, 
Fargo, ND, USA. All 5 snap bean genotypes 
evaluated in this study were planted and grown 
(crop year 2014) in field plots at the Oregon 
State University Vegetable Research Farm, 
Corvallis, Oregon. The soil type of the vegetable 
research farm is Chehails silty clay loam soil 
and located at latitude N44.571209, longitude 
W123.243261 at 77 m.a.s.l. The site is 
continuously planted with snap bean over the 
years and randomized complete block design 
was used. All standard field practices were used 
to plant, grow, and harvest snap beans (Kleintop 
et al., 2016). After harvest snap beans pods were 
immediately frozen and transported to North 
Dakota State University for biochemical 
analyses. 
In a separate experiment, snap been 
seeds collected from Oregon State University, 
Corvallis, USA were grown in the greenhouse 
(AES Research Complex Greenhouse, North 
Dakota State University, Fargo, ND, USA) in 
2015. Snap bean plants were grown in 15 cm 
diameter pots using professional grade potting 
mix. The greenhouse temperature was kept 
constant between 25 and 26°C. A photoperiod 
of 14 h light and 10 h dark was used, and 
beneficial nematodes (weekly application) were 
used to minimize thrips and other insect 
infestation in the greenhouse. Each genotype 
was planted in eight pots and used as biological 
replicates. After harvest, pods were transferred 
to the laboratory and were frozen immediately 
before extraction. Prior to cold-water extraction, 
all pods were washed with distilled water and 
excess water was soaked and blotted out using 
paper towel. The chemical reagents used for 
biochemical analysis were porcine pancreatic α-
amylase, starch, equivalent of intestinal α-
glucosidase from yeast (Saccharomyces 
cerevisiae), p-nitrophenyl-α-D-
glucopyranoside (pNPG) and ABTS+ radical 
cation-decolorization agent. All chemicals were 
purchased from Sigma Chemical Co. (St. Louis, 
MO, USA). 
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Sample Extraction. Pod samples were 
cut into small pieces and weighed. Green snap 
bean pods of each genotype were extracted 
separately using distilled water at a ratio of 20 g 
of the sample (pod) per 50 mL of distilled water. 
All samples were homogenized for 10 minutes 
using a Waring blender. The samples were later 
centrifuged at 10,015 g for two times with 20 
min each. The supernatant was collected and 
stored at 2°C in refrigerator during the study 
period. Only aqueous extracts were targeted, as 
these are the most relevant for physiological and 
metabolic function in terms of digestion and 
anti-hyperglycemic functional properties. 
Total Soluble Phenolic Content. Total 
soluble phenolic content of snap bean aqueous 
extract was determined by a method described 
by Shetty et al. (Shetty et al., 1995). In brief, 0.5 
mL of the sample was transferred to a test tube 
and mixed with 0.5 mL of water, 1 mL of 95% 
ethanol and 5 mL of distilled water. To each 
sample, 0.5 mL of 50% (v / v) Folin-Ciocalteau 
reagent was added and mixed. After 5 min, 1 mL 
of 5% Na2CO3 was added and mixed and then 
kept in the dark for 60 min incubation. After 60 
min incubation the absorbance of the sample 
was read at 725 nm using UV/VIS 
spectrophotometer (Thermo Fisher Scientific, 
Waltham, MA, USA). The absorbance values 
were converted into total soluble phenolic 
content and expressed in micrograms per gram 
of fresh weight (FW). Standard curves were 
established using various concentrations of 
gallic acid in 95% ethanol. 
Antioxidant Activity by ABTS [2, 2'-
azinobis(3-ethylbenzothiazoline-6-sulfonic 
acid)]Free Radical Scavenging Assay. Total 
antioxidant activity of aqueous extract of snap 
bean pods was determined by the ABTS + free 
radical cation scavenging assay (Re et al., 
1999). ABTS (Sigma Chemical Co. St. Louis, 
MO) reagent was dissolved in water to a 
concentration of 7 mM. Then ABTS stock 
solution was prepared using 5 mL of 7 mM 
ABTS with 88 µL of 140 mM potassium 
persulfate. The mixture was allowed to stand in 
the dark at room temperature for 12-16 h prior 
to use in the assay. Before being added to the 
sample, the stock solution was diluted with 
ethanol (95%) in the ratio 1:88 to obtain an 
absorbance of 0.70 ± 0.02 at 734 nm and was 
equilibrated at 30°C. One milliliter of the ABTS 
solution was then added to glass tubes 
containing 50 µL of sample extract and then 
mixed using vortex for 30 sec. After 2.5 min of 
incubation, the absorbance of the mixture was 
read at 734 nm using UV/VIS 
spectrophotometer (Thermo Fisher Scientific, 
Waltham, MA, USA). The readings were 
compared with controls, which contained 50 µL 
of 95% ethanol instead of aqueous extract of 
snap bean green pods. The Trolox reference 
standard for relative antioxidant activities was 
prepared with 5 mM stock solution of Trolox in 
ethanol. Percent inhibition was calculated by:  
 
 
α-Amylase Inhibitory Activity Assay. 
Porcine pancreatic α-amylase was purchased 
from Sigma Chemical Co (St. Louis, MO, 
USA). A volume of 500 µL of supernatant and 
500 µL of 0.02 M sodium phosphate buffer (pH 
6.9 with 0.006 M sodium chloride) containing 
α-amylase enzyme solution (0.5 mg.mL-1) was 
incubated at 25ºC for 10 min. After pre-
incubation, 500 µL of a 1% starch solution in 
sodium phosphate buffer 0.02 M (pH 6.9 with 
0.006 M NaCl) was added to each test tube at 
timed intervals (Kwon et al., 2007). The 
reaction mixtures were then incubated at 25ºC 
for 10 min. The reaction was stopped by adding 
1.0 mL of 3, 5-dinitro salicylic acid (DNS) color 
reagent. The test tubes were then incubated in a 
water bath with boiling water (90-100 ºC) for 10 
min and later cooled at room temperature. The 
reaction mixture was then diluted upon addition 
of 10 mL of distilled water and the absorbance 
of the sample was measured at 540 nm using 
UV/VIS spectrophotometer (Thermo Fisher 
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Scientific, Waltham, MA, USA). Percent 
inhibition was calculated as follows: 
 
 
α-Glucosidase Enzyme Inhibitory Activity 
Assay. α-Glucosidase assay was performed 
using 50 µL of the supernatant and 100 µL of 
0.1 M phosphate buffer (pH 6.9) containing α-
glucosidase solution (1.0 U.mL-1) and 
incubated in 96-well plates at 25°C for 10 min 
(Kwon et al., 2007). After pre-incubation, 50 
µL of a solution of 5 mM p-nitrophenyl-α-D-
glucopyranoside in 0.1 M phosphate buffer 
(pH 6.9) was added to each well at time 
intervals. The reaction mixtures were then 
incubated at 25°C for 5 min. Before and after 
incubation, the absorbance readings were 
recorded at 405 nm by a microplate reader 
(Thermomax, Molecular Device Co., 
Virginia, USA) and compared with a control, 
which contained 50 µL of buffer instead of 
aqueous extract of pods. The inhibitory 
activity of α- glucosidase was expressed as % 
inhibition and calculated as follows: 
 
 
Phenolic Acid Profile Determination 
Using High Performance Liquid 
Chromatography (HPLC). Green pod sample 
extracts of snap beans were micro- centrifuged 
for 10 min at 13,000 rpm, from which a small 
volume (5 µL) of the sample was subjected to 
chromatographic analysis using reverse phase 
HPLC (Agilent 1260 Infinity Series equipped 
with DAD 1100 diode array detector; Agilent 
Technologies, Palo Alto, CA). A gradient 
elution method, involving 10 mM phosphoric 
acid (pH 2.5; Solvent A) and 100% methanol 
(Solvent B), was used. Sample extracts were 
eluted on a C-18 analytical column (Agilent 
Supelco SB-C18 250 × 4.6 mm internal 
diameter) with a packing material particle size 
of 5 µm, at a flow rate of 0.7 mL/min at ambient 
temperature, with a total run time of 25 min. 
Pure standards of gallic acid, catechin, 
chlorogenic acid, ferullic acid, quercetin, p-
coumaric acid, and kaemferol in 100% methanol 
were used to calibrate retention times on the 
standard curve. The chromatograms so obtained 
were analyzed using the Agilent Chemstation 
integration software. 
 
Statistical Analysis. The entire 
laboratory based biochemical (in vitro) and 
bioactive analysis was repeated four times from 
same snap bean sample obtained from Oregon 
State University from crop year 2014 and also 
from the greenhouse experiment at North 
Dakota State University in 2015. The analysis of 
each experiment were performed in triplicates. 
The means and standard deviations were 
calculated from the replicates of the 
experiments and analysis were performed using 
Microsoft Excel XP. Data were subjected to 
analysis of variance (ANOVA) to determine the 
significant differences between treatments. 
Significant differences were analyzed using 
Tukey test (P<0.05) by the R program (www.r-
project.org). 
 
RESULTS 
Total Soluble Phenolic (TSP) Content 
and Total Antioxidant (TA) Activity. Total 
soluble phenolic (TSP) content and total 
antioxidant (TA) activity of snap bean 
genotypes from field and greenhouse were 
determined. Statistically significant variations 
in TSP content and TA activity was observed 
between snap bean genotypes (p<0.05) (Figure 
1 A, B & 2 A, B).  
The TSP content of aqueous extracts of 
snap bean pods ranged from 197.9 to 330.5 
(µgGAE. g-1 FW) in field grown pods (Figure 
1A) and 127.8 to 322.4 (µgGAE. g-1 FW) in 
greenhouse grown pods. In the field grown pods, 
highest TSP content was found in Tendergreen 
followed by OR 5630 (Figure 1A). Interestingly, 
when grown under greenhouse condition 
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Tendergreen had lowest TSP content, while OR 
5630 had higher TSP content (Figure 1B). The 
variation of TSP content in Tendergreen might 
be due to the different growing condition 
(between field and greenhouse) or due to some 
other environmental factors.  
 
  
The TA activity of 5 snap bean genotypes varied 
significantly (p<0.05) and ranged from 32.6 to 
79.3% (ABTS % inhibition) in pods grown 
under field condition (Figure 2A) while 43.0 to 
89.6 % (ABTS % inhibition) in snap beans 
grown under greenhouse condition (Figure 2B). 
Similar to the TSP content, Tendergreen snap 
bean genotype had significantly higher (p<0.05) 
TA activity followed by Ebro, OR 5630, Eagle, 
and Bogota from field experiment (Figure 2A). 
In the greenhouse experiment higher TA activity 
was observed in Ebro snap bean genotype 
followed by OR 5630, Bogota, and Eagle 
(Figure 2B). Like TSP content, lower TA 
activity was observed in Tendergreen snap bean 
genotype grown under greenhouse conditions 
(Figure 2B).  
 
α-Amylase and α-Glucosidase 
Inhibitory Activity. In this study, significant 
differences in α-amylase inhibitory activity was 
observed among 5 snap bean genotypes 
(p<0.05) (Figure 3A, B). Alpha-amylase 
enzyme inhibitory activity of aqueous pod 
extracts of snap bean genotypes grown under 
field condition was ranged from 43.9 to 83.6 (% 
inhibition) (Figure 3A), while it was ranged 
between 26 to 80 (% inhibition) in snap bean 
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pods grown under greenhouse condition (Figure 
3B). Among snap bean genotypes OR 5630 and 
Bogota had higher α- amylase enzyme 
inhibitory activity when compared to Eagle and 
Ebro. Similar to TSP content and TA activity, α-
amylase inhibitory activity of Tendergreen snap 
bean genotype varied significantly between 
field and greenhouse experiments.  
 
 
Inhibitory potentials of snap bean genotypes 
against another key digestive enzyme, α-
glucosidase was also evaluated using in vitro 
assay model. Significant dose dependent response 
(undiluted, half-diluted, and one-fifth diluted) in 
α- glucosidase inhibitory activity was observed in 
all 5 snap bean genotypes in both field and 
greenhouse grown pods (Table 1). In undiluted 
sample, α-glucosidase enzyme inhibitory activity 
of snap bean genotypes from field experiment 
ranged from 24.9 to 50.5 (% inhibition), while it 
ranged between 26.4 to 52.6 (% inhibition) in 
greenhouse grown pods. Among snap bean 
genotypes Eagle and Ebro had higher α-
glucosidase enzyme inhibitory activity at all 
doses when compared with other 3 snap bean 
genotypes and under both greenhouse and field 
conditions (Table 1). Overall low to moderate α-
glucosidase enzyme inhibitory activity was 
observed in this study. 
 
 
 
Phenolic Acids Profile. Individual 
phenolic acids of 5 snap bean genotypes were 
determined using HPLC method. Major 
phenolic acids detected in this study were 
quercetin, catechin, and gallic acid (Table 2). 
Previous studies have detected quercetin, 
kaempferol, rutin, catechin and epicatechin as 
major phenolic acids in green pods of green 
bean cultivars (Abu-Reidah et al. 2013; Escarpa 
and González, 2000). Use of different solvent, 
extraction types, and HPLC protocol used in this 
study may have contributed for detecting only 3 
phenolic acids in snap bean genotypes. Similar 
to TSP content higher concentrations of 
individual phenolic acid, especially quercetin 
was also observed in Tendergreen snap bean 
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genotype grown under field condition when 
compared to others (Table 2). 
DISCUSSION 
Since secondary metabolites, such as 
phenolic bioactives of food crops have 
relevance in cellular redox-regulation it can also 
translate into therapeutic and medicinal 
properties and human health benefits for 
managing oxidation breakdown-linked NCDs, 
such as T2D. Therefore, targeting food crops 
with higher phenolic antioxidant profile for 
therapeutic applications against oxidative- 
stress linked T2D has sound rationale. However, 
phenolic bioactive profiles and associated 
human health benefits of food crops including 
snap beans targeted in this study vary 
significantly among genotypes, different 
growing conditions (environment), and between 
genotype × phenotype × environment 
interactions (Kleintop et al., 2016).  
 
 
Therefore, rapid in vitro screening of 
different genotypes of snap beans for human 
health relevant phenolic antioxidant profile and 
associated functionalities targeting chronic 
diseases has significant merit for further 
development of superior varieties and wider use 
for medicinal and therapeutic applications. 
Based on this context and biochemical rationale, 
5 different snap bean genotypes both from field 
(one year) and greenhouse experiments were 
evaluated and screened for phenolic 
antioxidant-linked anti- hyperglycemic 
functionality targeting early stages of T2D using 
rapid in vitro assay models. This provides the 
biochemical-based rationale and foundation for 
further development of targeted varieties for 
wider health targeted applications. 
Overall, moderate level (127.8 to 330  
µgGAE. g-1 FW) of TSP content was found in 
all 5 snap bean genotypes targeted in this study 
and grown under field and greenhouse 
conditions, which has relevance for diverse 
human health benefits of phenolic bioactives 
including their antioxidant-linked anti-
hyperglycemic functionality that was evaluated 
subsequently in this study. Baardseth et al. 
(Baardseth et al., 2010) previously reported 
similar range of TSP content in other green bean 
genotypes (221 µgGAE. g-1 FW ). Although 
Kleintop et al. (2016) also reported significantly 
higher TSP content (1.01 mgGAE. g-1 FW) in 
Tendergreen, the level of TSP content of OR 
5630 reported by the same study was similar to 
the finding in this study. The higher level of TSP 
content in Tendergreen in earlier study might be 
due to the use of different solvents (acetone 
based extract), and extraction protocols, or due 
to the differences in crop year (crop year 2010), 
as growing conditions and environment could 
have significantly contributed to the higher level 
of TSP in Tendergreen (Kleintop et al., 2016). 
The level of TA activity of snap bean genotypes 
observed in this study was significantly higher 
than what another study reported previously 
(Gomes et al., 2009). Overall, moderate TSP 
content and moderate to high TA activity of 
snap bean genotype (OR5630) grown under 
both field and greenhouse conditions found in 
this study could potentially have significant 
relevance for potential therapeutic applications 
against chronic oxidative stress associated with 
T2D and other NCDs.   
Previously, the anti-hyperlipidemic and 
antioxidant activity in aqueous extract of dried 
green beans was reported (Venkateswaran and 
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Pari, 2002). The anti- hyperlipidemic effect of 
this previous study was targeted for reduction in 
blood glucose level, triglycerides, free fatty 
acids, phospholipids and total cholesterol when 
bean extracts were administered in diabetes-
induced rats (Venkateswaran and Pari, 2002). 
The pathogenesis of T2D typically involves 
increase of free radicals in the body coupled 
with the deficiency of antioxidant protection and 
further chronic oxidative stress from free 
radicals that are formed disproportionately by 
higher glucose oxidation, glycation of non-
enzymatic proteins and subsequent oxidative 
degradation of glycosylated proteins (Ceriello, 
2000; Maritim et al., 2003). However, food 
crops such as snap beans with moderate level of 
phenolic bioactive-linked antioxidant capacity 
have potential to provide protection against such 
chronic oxidative stresses and therefore, can be 
targeted for the medicinally relevant dietary and 
therapeutic applications against oxidation-
linked chronic inflammation commonly 
associated with early stages T2D. Furthermore, 
inhibition of digestive enzymes, such as α-
amylase and α- glucosidase with non-synthetic 
and natural plant based sources is a safe 
therapeutic strategy to prevent and manage 
chronic hyperglycemia linked to early stages 
T2D (Hanhineva et al., 2010; Kwon et al., 
2007). In addition, a 45-75% α-amylase 
inhibitory activity was reported in beans 
previously (Melzig and Funke, 2007). The role 
of α- amylase in glucose metabolism is related 
to its ability for catalyzing the hydrolysis of α-
1,4 glycosidic bond of starch, glycogen, and 
other oligosaccharides which results in the rapid 
release of simple sugars in the intestine (Ali et 
al, 2006; Pereira et al., 2010). However, the 
inhibition of this enzyme in the human digestive 
tract helps to manage postprandial 
hyperglycemia by slowing down the breakdown 
of starch and other complex carbohydrates 
(Negri and Negri, 2005). Overall, moderate to 
high α-amylase enzyme inhibitory activity was 
observed in all 5 snap bean genotypes in this 
study, and therefore these genotypes can be 
targeted in medicinally relevant therapeutic 
strategies to manage hyperglycemia-linked to 
T2D. 
Managing postprandial hyperglycemia 
is critical for overall management of T2D 
(Baron, 1998). Therefore, controlling 
postprandial glucose level in the blood is of 
utmost importance in the treatment of T2D and 
its associated macro and micro-vascular 
complications (Ali et al., 2006; Subramanian et 
al., 2008). Thus, several synthetic and non-
synthetic natural sources that have potential to 
inhibit α- amylase and α-glucosidase were 
evaluated and then targeted to design 
pharmaceutical drugs for T2D treatments 
(Kobayashi et al., 2000). However, synthetic 
inhibitors can cause significant side effects, 
some of which may increase the incidence of 
renal tumors, can cause liver damage, and acute 
hepatitis (Carascosa et al., 1997; Charpentier et 
al., 2000). Therefore, finding non-synthetic 
natural sources with moderate to high α-amylase 
and α-glucosidase has significant relevance for 
long-term and safe management of T2D using 
therapeutic strategies. In this context snap bean 
genotypes such as OR5630, Ebro, and Eagle can 
be targeted and integrated in medicinally 
relevant diets or in therapeutic strategies to 
control hyperglycemia-linked to early stages of 
T2D. 
The health relevant benefits of food 
crops are not only just associated with total 
soluble phenolic content but also based on the 
composition of phenolic bioactives. Among 
detected phenolic acids, higher concentrations 
of quercetin was observed in all snap bean 
genotypes both under field and greenhouse 
conditions. Quercetin is most abundant flavonol 
widely distributed in different plant species and 
has significant human health benefits (Larson et 
al., 2012). Reduction of serum cholesterol and 
phospholipid levels was observed in rat with 
addition of 1% quercetin in diet (Odbayar et al., 
2006). Similarly, reduction of blood pressure 
was also found with quercetin supplementation 
in hypertensive subjects (Edwards et al., 2007). 
Therefore, higher level of quercetin in snap bean 
pods may have significant relevance in 
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managing macro and micro-vascular risks such 
as hypertension and dyslipidemia, which are 
commonly associated with T2D. Quercetin, 
gallic acid, and catechin are also known as 
natural antioxidants and have significant human 
health benefits including anti-inflammatory 
properties (Saibabu et al., 2015). Anti-
hyperglycemic and anti-lipidperoxidative 
properties of gallic acid was observed in 
diabetic rats (Punithavathi et al., 2011). 
Similarly, consumption of catechin rich 
beverage has also shown improvement in blood 
glucose control in T2D patients (Nagao et al., 
2009). Therefore, the major phenolic acids 
found in snap bean genotypes in this study have 
potential to contribute to the evaluated 
antioxidant and anti-hyperglycemic functions 
and can be targeted as functional biomarkers in 
therapeutic strategies for management of early 
stages of T2D and its associated complications. 
CONCLUSION 
Legumes such as snap beans are 
considered as healthy food choices due to their 
diverse bioactive profiles including phenolic 
metabolites. However, these phenolic bioactives 
and associated health benefits of snap bean vary 
widely among different genotypes and due to 
growing conditions. Therefore, prior to the 
targeted utilization of snap beans in medicinally 
relevant therapeutic strategies, it is essential to 
screen and evaluate different genotypes and 
from different growing conditions for their 
optimum phenolic bioactive-linked anti-
hyperglycemic functionality using rapid in vitro 
assay models. Overall, moderately high and 
relevant TSP content, hig h TA acti vit y and 
high α-amylase inhibitory activity were found in 
Oregon5630 snap bean genotypes, while high α-
glucosidase inhibitory activity was observed in 
Ebro and Eagle genotypes in this study. 
However, significant variations in phenolic-
linked antioxidant and anti- hyperglycemic 
functionalities were observed in Tendergreen 
genotype when compared between field and 
greenhouse growing conditions and therefore, 
needs further evaluation. However, snap bean 
genotypes with moderate phenolic-linked anti-
hyperglycemic functionality can be targeted in 
therapeutic strategies against chronic 
hyperglycemia and chronic oxidative stress, 
commonly associated with early stages T2D. 
Further clinical studies with animal models and 
wider screening of other snap bean genotypes 
for medicinally relevant targeted properties are  
required to validate the findings of this in vitro 
study and further to advance the use of snap 
bean in medicinally relevant therapeutic 
intervention strategies targeting early stages of 
T2D and associated risks. 
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